Can you pick which of your breast cancer patients will have a recurrence?
There’s no way to predict which of your patients will have recurring breast cancer. So it makes sense to treat all patients as women with some risk. Versus tamoxifen, Arimidex can improve every patient's chance of staying disease free.
Agency of the Year X Country Winners Showcase Creativity Defined by CultureRead More
McCann New York Wins 2017 Super Clio for a “Genius” National Geographic SpotRead More
How Agency of the Year X Country Winners Find Inspiration In Global and Tech TrendsRead More
How Havas CCO Jason Peterson Became the Advertising King of InstagramRead More